Bone marrow cancer discovery points to potential drug targets
New research from Mayo Clinic's Center for Individualized Medicine finds that patients with ASXL1-mutant chronic myelomonocytic leukemia—an uncommon type of cancer of the bone marrow—have distinctive epigenetic changes ...
Mar 17, 2022
0
67